1. We reported baseline characteristics of the patients including type and duration of diabetes mellitus, insulin use, severity of diabetic retinopathy, presence of systemic diseases, and the most recent HbA1C level in the first table of the original manuscript (1). All these variables give important information on the identifying features of the study population. 2. The limitations of the study including retrospective nature and a small number of patients were mentioned in the discussion. 3. As the authors mentioned, in our study the always damage group had worse disease that required combined treatment. 4. Though the authors suggested categorizing patients based on the presence or absence of clinically significant macular edema, in recently published clinical trials, this classification has not been used (2) . Indeed, it is a historical term that was used in clinical trials before the introduction of optical coherence tomography. 5. In our study, both groups showed some improvement following resolution of diabetic macular edema (DME); as expected, the mean increase in visual acuity was higher in eyes with baseline damage compared to those with always inner segment/outer segment junction layer damage. The limited vision gain in the always damage groups may be explained by the upregulation of inflammatory markers, as suggested. However, we do not believe that ischemia is a confounding variable related to the limited vision gain due to the fact that ischemic eyes were excluded from the study. 6. In a study with a small number of patients, it would not be possible to include all parameters suggested by the authors. Though they may have an impact on the final vision or final status of the photoreceptors, further studies with larger sample size are needed to show the effect of these variables. On the other hand, the majority of the variables mentioned by the authors have been extensively studied in previous reports (3) (4) (5) . Thus, including all the potential variables would not yield any significance in such a population with a small number of patients.
We showed that though photoreceptors can be damaged during DME, 44% of patients with less photoreceptor damage at baseline and shorter duration of DME achieved complete restoration of photoreceptors. Thus, promptness of DME treatment is important to achieve optimal functional and anatomic outcomes.
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